Brief: AnaptysBio's Complaint Against Tesaro For Breaching Agreement Was Publicly Filed On Nov 26 - SEC Filing
26/11/2025 21:09
Nov 26 (Reuters) - AnaptysBio Inc ANAB.O: ANAPTYSBIO INC - ON NOV 26, CO'S COMPLAINT AGAINST TESARO FOR BREACHING AGREEMENT WAS PUBLICLY FILED - SEC FILING ANAPTYSBIO INC - ON NOV 26, TESARO & GSK PUBLICLY FILED THEIR COMPLAINT AGAINST CO ALLEGING BREACHED COLLABORATION AGREEMENT Source text: [ID:n0001370053-25-000103] Further company coverage: ANAB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on AnaptysBio
See all newsFirst Tracks Biotherapeutics up after $200 mln equity raise
US RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Brief: Anaptys Announces Second Quarter And Transitional Fiscal Year 2026 Financial Results And Provides Business Update
AnaptysBio Q2 collaboration revenue rises on higher Jemperli royalties